-
3 weeks ago | 
webmd.com | David Brzostowicki
June 2, 2025 – Atkins, paleo, grapefruit, soup: Fad diets come, fad diets go. With one glaring exception. Recent estimates show that 13 million Americans follow a ketogenic diet – a nutrition paradigm based on extremely low carbs and high fats – and its popularity is only growing. "This one's hardly a fad, since it's over 100 years old," said Ethan Weiss, MD, a preventive cardiologist at the University of California, San Francisco.
-
1 month ago | 
medscape.com | David Brzostowicki
The first death of a patient represents a profound emotional turning point that reverberates throughout one’s career as a physician. In that critical moment, the shield of clinical detachment gives way to inevitable self-reflection. Daryl Eber, MD, recalls a jarring case of an intubated patient who extubated himself and quickly died after coding.
-
2 months ago | 
webmd.com | David Brzostowicki
April 29, 2025 – Prostate cancer is the second-deadliest cancer among U.S. men – and it's on the rise. More than 300,000 men are diagnosed with the condition each year, a number that's been climbing by 3% annually since 2014, according to the American Cancer Society. The reasons come down to a few different things. Screenings have gone up, so more cases are being identified.
-
2 months ago | 
webmd.com | David Brzostowicki
April 3, 2025 – In the U.S. at any given time, thousands of adults and hundreds of children are on waiting lists for a lifesaving heart transplant, facing waits of six months or longer. Some will die in the interim, including one out of every eight children on the list. Worldwide, about 20 people die per day while waiting for any organ.
-
Mar 11, 2025 | 
espanol.medscape.com | David Brzostowicki
Encuentre las últimas noticias y orientación acerca de la COVID-19 en el Centro de información sobre el coronavirus (SARS-CoV-2).
-
Feb 21, 2025 | 
mdedge.com | David Brzostowicki
FROM JAMAA new analysis of long-COVID patients has identified five distinct subtypes that researchers say will help doctors diagnose the condition. The new five-type index, developed by federal researchers with the National Institutes of Health’s RECOVER COVID Initiative, identified the most common symptoms in 14,000 people with long COVID, with data from an additional 4000 people added to the updated 2024 index.
-
Jan 8, 2025 | 
mdedge.com | David Brzostowicki
A new light therapy device could be a game-changer for millions at risk of vision loss. The Food and Drug Administration (FDA) has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55. Developed by LumiThera, the device showed promising results in a clinical trial, marking it as the first effective therapy for AMD. Approved under the FDA’s “De Novo” process, the treatment offers hope where no similar options existed.
-
Jan 6, 2025 | 
webmd.com | David Brzostowicki
Jan. 7, 2025 – A new light therapy device could be a game-changer for millions at risk of vision loss. The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration, a leading cause of blindness in adults over 55. Developed by LumiThera Inc., the device showed promising results in a clinical trial, marking it as the first effective therapy for AMD. Approved under the FDA’s “De Novo” process, the treatment offers hope where no similar options existed.
-
Dec 5, 2024 | 
webmd.com | David Brzostowicki
Dec. 5, 2024 -- More than 1 in 8 Americans have taken Ozempic, the popular diabetes and weight loss drug. That makes it one of the most popular medications in history just seven years after hitting the market, with Ozempic and similar drugs the most popular class of medications by overall spending in the U.S. in 2023. This surge in popularity has been relatively sudden, with the pandemic and celebrity influencers playing no small part in its marketing.
-
Oct 22, 2024 | 
mdedge.com | David Brzostowicki
FROM NATURELong COVID, a major public health crisis, is also becoming a significant economic crisis. A new study in Nature reports that the global annual economic impact of long COVID has hit $1 trillion — or about 1% of the global economy. Long COVID is estimated to affect 6%-7% of adults. Those afflicted are often unable to work for extended periods, and some simply stop working altogether.
